Biomarkers and Cardiac CT

Recruiting now

Conditions studied: Coronary Artery Disease, Atherosclerosis

In brief

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in developed countries. In addition, many patients suffer from valvular and aortic disease. Although various tools are available to identify patients with cardiovascular (CV) disease at risk for major adverse cardiac events (MACE), the identification of these patients remains a clinical challenge. One promising avenue is the use of different serum biomarkers involved in atherothrombosis which could provide an easy and cost-effective step in risk stratification.

Key facts

Study ID

NCT02381301

Run by

Maastricht University Medical Center

People needed

5000

Starts

2015-02-01

Expected to finish

2029-12-01

Last updated by the study team

2017-03-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients referred from the Cardiology clinic for routine CCTA.

You may not qualify if…

• Pregnancy
• Severe renal insufficiency
• Severe allergy to contrast medium
• Inability to obtain informed consent
• Age below 18 years

Where it is running

• Maastricht University Medical Center — Maastricht, Limburg, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.